title: Febrifugine analogue compounds: synthesis and antimalarial evaluation.
abstract: Febrifugine is an alkaloid isolated from Dichroa febrifuga Lour as the active component against Plasmodium falciparum, but exhibits toxic side effects. In this study novel febrifugine analogues were designed and efficiently synthesized. New compounds underwent efficacy and toxicity evaluation. Some compounds are much less toxic than the natural product febrifugine and existing antimalarial drugs and are expected to possess wide therapeutic windows. In Aotus monkeys infected with the chloroquine resistant FVO strain of P. falciparum, one interesting compound possesses a 50% curative dose of 2mg/kg/day and a 100% curative dose of 8 mg/kg/day. These compounds, as well as the underlying design rationale, may find usefulness in the discovery and development of new antimalarial drugs.
authors.affiliation: Radix Pharmaceuticals, Inc., 20271 Goldenrod Lane, Suite 2035, Germantown, MD 20876, USA. shuren.zhu@gmail.com
authors.forename: Shuren
authors.initials: S
authors.lastname: Zhu
authors.forename: Gudise
authors.initials: G
authors.lastname: Chandrashekar
authors.forename: Li
authors.initials: L
authors.lastname: Meng
authors.forename: Katie
authors.initials: K
authors.lastname: Robinson
authors.forename: Dipsanker
authors.initials: D
authors.lastname: Chatterji
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001029:Aotus trivirgatus; D004353:Drug Evaluation, Preclinical; D008288:Malaria / Q000188:drug therapy; D010880:Piperidines / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D010963:Plasmodium falciparum / Q000187:drug effects*; D011799:Quinazolines / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
chemical_list: D000962:Antimalarials; D010880:Piperidines; D011799:Quinazolines; C001207:febrifugine